Acute Kidney Injury as a Risk Factor for Myocardial Injury and Ventricular Dysfunction
Assessment of Acute Kidney Injury as a Risk Factor for Myocardial Injury and Ventricular Systolic Dysfunction After Non-Cardiac Surgery in Critical Patients
1 other identifier
observational
520
1 country
1
Brief Summary
Acute kidney injury (AKI) is classically described as an abrupt or rapidly reversible reduction in the excretion of nitrogenous waste products, including urea, nitrogen and creatinine. Acute kidney injury definition emphasizes on the filtration function of the kidney, a measure that is unique and easily and routinely measured . Acute kidney injury is associated with significantly increased resource utilization and health care costs. Major adverse cardiac events (MACE) after non cardiac surgery are a leading cause of morbidity and mortality. The reported incidence of postoperative myocardial infarction (POMI) among patients undergoing non cardiac surgery is between 3% and 6%.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2020
CompletedFirst Submitted
Initial submission to the registry
February 20, 2021
CompletedFirst Posted
Study publicly available on registry
February 24, 2021
CompletedFebruary 24, 2021
February 1, 2021
1.5 years
February 20, 2021
February 23, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
development myocardial injury
New echocardiographic findings suggestive of ischemia (new regional wall motion abnormalities) or cardiac troponin T \>.0.32 ng/ml
through study completion, an average of 15 days
Interventions
Urea, BUN, and Creatinine BLOOD LEVELS
Eligibility Criteria
Patients with normal kidney functions and free normal heart functions
You may qualify if:
- Patients with normal kidney functions and free normal heart functions, were enrolled to this study
You may not qualify if:
- patients with chronic kidney disease, cardiac disease, who with minor operations, or emergency, were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alaa Ali Elzohry
Asyut, +2071516, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- 4- Lecturer of Anesthesia, ICU and Pain Relief, South Egypt Cancer Institute, Assiut University, Egypt
Study Record Dates
First Submitted
February 20, 2021
First Posted
February 24, 2021
Study Start
March 5, 2019
Primary Completion
August 20, 2020
Study Completion
August 30, 2020
Last Updated
February 24, 2021
Record last verified: 2021-02